Anaphylaxis as the only presenting symptom  of COVID 19

Reem Abuzraiq; Suleimman Al-Sweedan; Dana Kanaan

doi:10.58877/japaj.v1i3.39

Authors

Reem Abuzraiq Department of Pediatrics/Faculty of Medicine, Jordan University of Science& Technology. https://orcid.org/0000-0002-7537-634X
Suleimman Al-Sweedan Department of Pediatrics/Faculty of Medicine, Jordan University of Science& Technology https://orcid.org/0000-0002-7779-9573
Dana Kanaan Department of Pediatrics/Faculty of Medicine, Jordan University of Science& Technology

DOI:

https://doi.org/10.58877/japaj.v1i3.39

Keywords:

Pediatrics; COVID-19; Anaphylaxis

Abstract

Most children with SARS-CoV-2 infection are asymptomatic or exhibit only mild symptoms. A varied incidence of cutaneous rashes has been described in different studies.A recent review of the cutaneous manifestations in patients with COVID-19 highlighted that urticarial rash is common at the onset of the disease but very rare cases found to have associated anaphylaxis. With this report, we are describing a 10-year-old child who presented to a tertiary care hospital in Jordan with anaphylaxis as the only presenting symptom of COVID-19.

References

She J, Liu L, Liu W. COVID-19 epidemic: Disease characteristics in children. J Med Virol. 2020;92(7):747-54. DOI: https://doi.org/10.1002/jmv.25807

Olisova OY, Anpilogova EM, Shnakhova LM. Cutaneous manifestations in COVID-19: A skin rash in a child. Dermatol Ther. 2020;33(6):e13712. DOI: https://doi.org/10.1111/dth.13712

Pagali S, Parikh RS. Severe urticarial rash as the initial symptom of COVID-19 infection. BMJ Case Rep. 2021;14(3). DOI: https://doi.org/10.1136/bcr-2021-241793

Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, et al. Mast cells and inflammation. Biochim Biophys Acta. 2012;1822(1):21-33. DOI: https://doi.org/10.1016/j.bbadis.2010.12.014

Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020;55(5):105954. DOI: https://doi.org/10.1016/j.ijantimicag.2020.105954

Mazur N, Patterson R, Perlman D. A case of idiopathic anaphylaxis associated with respiratory infections. Annals of Allergy, Asthma & Immunology. 1997;79(6):546-8. DOI: https://doi.org/10.1016/S1081-1206(10)63064-5

Bach M, Lim PP, Azok J, Ruda Wessell K, Desai AP, Dirajlal-Fargo S. Anaphylaxis and Rhabdomyolysis: A Presentation of a Pediatric Patient With COVID-19. Clin Pediatr (Phila). 2021;60(4-5):202-4. DOI: https://doi.org/10.1177/0009922821999470

Tole JW, Lieberman P. Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations. Immunology and allergy clinics of North America. 2007;27(2):309-26. DOI: https://doi.org/10.1016/j.iac.2007.03.011

Fida M, Mala R, Pupo L, Dibra A, Nasto K. Case report: SARS-CoV-2-induced urticaria or just a concomitance? Dermatol Ther. 2020;33(6):e14250. DOI: https://doi.org/10.1111/dth.14250